170 results on '"Colantuono, Stefania"'
Search Results
2. B Cell in Health and Disease
3. The New Paradigm: The Role of Proteins and Triggers in the Evolution of Allergic Asthma
4. Severe asthma: One disease and multiple definitions
5. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
6. Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
7. RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists.
8. CD21low B cells in systemic sclerosis: A possible marker of vascular complications
9. The last step to achieve barrier damage control
10. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
11. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)
12. A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders
13. Immunoglobulin Free Light Chains in Severe Asthma Patient: could they be a new biomarker?
14. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia.
15. Clinical research coordinators: Key components of an efficient clinical trial unit
16. Clinical research coordinators: Key components of an efficient clinical trial unit
17. Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review
18. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity
19. Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia
20. Delayed hypersensitivity to dimethyl fumarate: report of one case and literature review
21. Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review
22. Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis
23. Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis
24. Clinical research coordinators: Key components of an efficient clinical trial unit
25. Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity
26. Heterogeneous Condition of Asthmatic Children Patients: A Narrative Review
27. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection
28. Heterogeneous Condition of Asthmatic Children Patients: A Narrative Review
29. Severe asthma: One disease and multiple definitions
30. The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti–hepatitis C virus therapy
31. Autoimmune hepatitis with eosinophilic infiltration responsive to anti-interleukin-5 receptor treatment: a case report and literature review.
32. Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review
33. β-Lactam Allergy and Cross-Reactivity: A Clinician’s Guide to Selecting an Alternative Antibiotic
34. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression
35. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy
36. CD21low B cells are predictive markers of new digital ulcers in systemic sclerosis
37. Cryoglobulins: putative effectors of adaptive immune response
38. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy
39. Mutational and immunogenetic landscape of HCV ‐associated B‐cell lymphoproliferative disorders
40. Cryoglobulins: putative effectors of adaptive immune response
41. Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression
42. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
43. Clinico‐immunological outcomes of HCV‐cured cryoglobulinemia: Lower relapse rate with interferon‐based than interferon‐free therapy
44. Basophil activation and serum IL‐5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti‐IL‐5 drugs
45. Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis
46. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar)
47. Biomarkers of minimal residual disease in rituximab‐treated patients with mixed cryoglobulinemia
48. Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study
49. Immunobiology of essential mixed cryoglobulinemia
50. Prospective Italian real‐world study of mepolizumab in severe eosinophilic asthma validates retrospective outcome reports.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.